Both public and private healthcare expenditures are coming under increasing pressure as costs rise as a fraction of GNP and new treatments outstrip patients’ ability to pay. The right pricing and market access strategy is essential to ensure patients can benefit from new therapies, as well as deliver commercial success for any new product launch. Irrespective of reimbursement status, it is vital to identify the best path to address price sensitivity and fast, reliable access routes to as many patients as possible. EVERSANA specializes in actionable solutions based on our deep understanding of pricing and access complexities presented by US markets of interest to EU clients. Our services include:
- 継続的に更新される当社独自のデータリポジトリから得た類推を使用して価格感度を分析します
- 参照価格メカニズムとそれが市場全体に及ぼすと予想される影響を評価します
- 異なる価格体系 （フラット、線形、非線形） の受容性を分析します
- 当社の（確率に基づく市場機会評価の基盤としての）支払者アドバイザーネットワークから出された意見に基づき、潜在的な費用償還シナリオを説明します
- 施術レベルでの摂取量を導出するための価格感度統計ツールに焦点を当てた市場調査を行います
- 非償還市場における商業的成功を測るための、臨床試験患者アフォーダビリティプログラムに固有のコンセプト
We have successfully advised our clients across the Europe region and western markets with varied levels of public reimbursement coverage.